CytoMed Therapeutics GDTC Ratios (2021-2026)

NASDAQ GDTC
$0.91 +0.04 (+4.42%)
As of: Oct 21, 2026 · 3:59 PM EDT
Reported Financials

CytoMed Therapeutics Quarterly Ratios

Periods 9 quarters
Latest Jun 2026

CytoMed Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 9 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2021 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025 Jun2026
Efficiency
Assets AverageAssets Avg. 8.90M11.64M10.14M9.16M7.88M7.29M6.62M
Equity AverageEquity Avg. 6.80M10.84M9.34M8.41M6.94M6.28M5.37M
Invested CapitalInvested Cap. 4.91M4.44M13.63M8.85M10.59M6.97M7.63M5.66M5.44M
Leverage & Solvency
Debt Ratio 0.671.030.030.040.040.040.050.050.01
Valuation
Price to BookP/B 1.836.642.365.903.602.972.26
Enterprise Value 13.70M49.73M17.53M35.66M23.19M14.53M11.15M
Market Capitalization 24.14M56.55M24.00M39.24M25.97M15.85M12.18M

CytoMed Therapeutics Ratios API

Pull CytoMed Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GDTC&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY